SEC Form 4 · accession 0001635088-26-000092
Roivant Sciences Ltd. · ROIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ilan Oren
Director
Period of report
Sep 10, 2026
Accepted (ET)
Sep 14, 2026 · 6:42 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001635088
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Sep 10, 2026 | F | 2,378 | $40.94 | D | 118,626 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.